Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $496.4K | conv 33Cluster | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $994.5K | conv 44ClusterFirst in 12mo | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $310.8K | conv 33Cluster | SEC | |
Tricida, Inc.Listing unverified | Buy | $2.6M | conv 37Cluster | SEC | |
Tricida, Inc.Listing unverified | Buy | $1.1M | conv 26Cluster | SEC | |
Tricida, Inc.Listing unverified | Buy | $759.9K | conv 25Cluster | SEC | |
Tricida, Inc.Listing unverified | Buy | $3.4M | conv 64ClusterUnusual size+1 | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Buy | $42K | conv 33Cluster | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Buy | $42.5K | conv 41ClusterFirst in 12mo | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Buy | $54K | conv 33Cluster | SEC |